Nrc Health (NRC) Current Deferred Revenue (2010 - 2026)

Nrc Health has disclosed Current Deferred Revenue across 17 years of filings, most recently posting $16.7 million for Q2 2026.

• In Q2 2026, Current Deferred Revenue rose 7.13% year-over-year to $16.7 million; the TTM figure through Jun 2026 stood at $16.7 million (up 7.13% YoY), while the FY2025 annual figure was $16.2 million, up 2.63% from the prior year.
• Current Deferred Revenue came in at $16.7 million for Q2 2026 at Nrc Health, down from $17.2 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $17.8 million in Q3 2025 to a low of $14.5 million in Q2 2024.
• Average Current Deferred Revenue over 5 years is $16.0 million, with a median of $15.8 million recorded in 2023.
• Year-over-year, Current Deferred Revenue declined 11.71% in 2022 and gained 10.87% in 2026.
• Over 5 years, Current Deferred Revenue stood at $15.2 million in 2022, then dropped by 2.4% to $14.8 million in 2023, then grew by 6.42% to $15.8 million in 2024, then climbed by 2.63% to $16.2 million in 2025, then gained by 3.18% to $16.7 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $16.7 million in Q2 2026, $17.2 million in Q1 2026, and $16.2 million in Q4 2025.